RecruitingPhase 1NCT06831474
Excretion of Rivaroxaban in Human Breast Milk
Sponsor
Thomas Jefferson University
Enrollment
10 participants
Start Date
Jul 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to investigate the distribution of rivaroxaban into human milk at both therapeutic and prophylactic doses, and over time with repeated dosing.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Rivaroxaban 10 MG Oral Tablet and a drug called Rivaroxaban 20 MG Oral Tablet for people with breast milk collection, breastfeeding, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGRivaroxaban 10 MG Oral Tablet
10mg rivaroxaban daily
DRUGRivaroxaban 20 MG Oral Tablet
20mg rivaroxaban daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06831474
Related Trials
Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis
NCT071402118 locations
Postpartum Vaginal Estrogen for Breastfeeding Patients
NCT054579721 location
Pumping to Up Maternal Milk Production for Preterms
NCT066731601 location
Early Life Exposures Among Children With Sickle Cell Disease
NCT053773721 location
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
NCT065570051 location